| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Keith S. Manchester | Director | 2026-11-17 | 798 | $38.24 | $30.52kSell |
| Daniel Allen Gold | Director | 2026-11-17 | 798 | $38.24 | $30.52kSell |
| Daniel Allen Gold | Director | 2026-11-17 | 525,507 | $38.24 | $20.10MSell |
| Daniel Allen Gold | Director | 2026-11-17 | 75,716 | $38.24 | $2.90MSell |
| Qvt Financial LP | Insider | 2026-11-17 | 798 | $38.24 | $30.52kSell |
| Keith S. Manchester | Director | 2026-11-17 | 75,716 | $38.24 | $2.90MSell |
| Qvt Financial LP | Insider | 2026-11-17 | 525,507 | $38.24 | $20.10MSell |
| Qvt Financial LP | Insider | 2026-11-17 | 75,716 | $38.24 | $2.90MSell |
| Keith S. Manchester | Director | 2026-11-17 | 525,507 | $38.24 | $20.10MSell |
| Keith S. Manchester | Director | 2026-11-16 | 550,280 | $39.17 | $21.55MSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Qvt Financial LP | 14.63% | 105,980,236 | $4.13B | Insider |
| Dexcel Pharma Technologies Ltd | 14.19% | 102,849,443 | $4.01B | Insider |
| Daniel Allen Gold | 13.98% | 101,306,228 | $3.95B | Insider |
| Svf Investments Uk Ltd | 10.08% | 73,031,667 | $2.85B | Insider |
| Sumitomo Chemical Co Ltd | 9.83% | 71,251,083 | $2.78B | Insider |
| Keith S. Manchester | 6.78% | 49,139,509 | $1.91B | Insider |
| Vivek Ramaswamy | 6.49% | 47,011,612 | $1.83B | Insider |
| Mayukh Sukhatme | 2.77% | 20,054,401 | $781.32M | Insider |
| Matthew Gline | 2.26% | 16,391,229 | $638.60M | Insider |
| Viking Global Investors LP | 1.78% | 12,884,307 | $501.97M | Insider |